revenue has continuously grown mainly due to its greater expansion of laboratory scopes of testing and analyzing for agricultural, food, and pharmaceutical associated with continual growing number of
% YoY to Bt24,019mn from robust growth of core service revenue offset by increased D&A following 4G investment. 3Q19 Financial Summary (Pre-TFRS 15 Revenue AIS has a strong total revenue growth of 7.9
% YoY to Bt24,019mn from robust growth of core service revenue offset by increased D&A following 4G investment. 3Q19 Financial Summary (Pre-TFRS 15 Revenue AIS has a strong total revenue growth of 7.9
million or 18.9% from Q2’2017, mainly from total green tea market declined but we still maintained as market leader and some part from fire incident of UHT production line, which was fully covered by
268.63 million Baht, increased 24.52 %, mainly caused income in year 2018 due to the business merger of domestic transport service by land, which is a subsidiary in late 2017 and merger and manufactures
the total revenues of 5,249 MTHB of which 5,216 MTHB earned from sales revenues. Sales revenues increased by 440 MTHB or 9.2% comparing to the same period of the year 2017. Such increase was mainly from
efficient of collection team, the Company’s net profit performance in 2018 reached to its highest in corporate history with net profit of 505.5 million Baht, increased at 27.6% from the previous year. The
efficient of collection team, the Company’s net profit performance in 2018 reached to its highest in corporate history with net profit of 505.5 million Baht, increased at 27.6% from the previous year. The
Baht 42.92 million:- 1. Total revenue was Baht 30.33 million, an increase by Baht 49.55 million or 258% mainly from: Return on financial instruments increased by Baht 55.64 million mainly from gain on
impairment loss from the liquidation of Solvay Biochemicals (Taixing) Limited (“SBT”) were fully booked in 2017. * Note Please find further information in the consolidated financial statements. 2 Summary of